Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms [Phase 2]
Phase 2 study in systemic sclerosis evaluating Avenciguat (BI 685509) for effects on lung function and other symptoms; the trial status is c…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
A clinico-biological collection study designed to investigate the pathophysiology of systemic autoimmune diseases, including systemic lupus …
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate [Phase 4]
Phase 4 trial evaluating the efficacy of tofacitinib on skin thickening in diffuse cutaneous systemic sclerosis, compared with methotrexate;…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases [NA]
A clinical trial evaluating EVM18001 for refractory autoimmune diseases is currently recruiting, including systemic lupus erythematosus, sys…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis [NA]
A clinical trial evaluating a personalized standardized rehabilitation program for systemic sclerosis has completed. This update notes the s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc) [Phase 1]
A Phase 1 study evaluating CT1190B for moderate-to-severe refractory systemic lupus erythematosus or refractory/progressive systemic scleros…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease [Phase 1]
Phase 1 study update for FT819 in B-cell–mediated autoimmune diseases; recruitment is ongoing for ANCA-associated vasculitis, idiopathic inf…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
A Cairo University-led study is recruiting to evaluate nutritional status in rheumatic diseases and its association with disease activity ac…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating a targeted CD19 or CD19-BCMA CAR-T therapy for autoimmune diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacaptagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating CD19-CAR T cells (Zola-cel/BMS-986353) versus standard of care in active sys…
-
CLINICAL_TRIALS withdrawal · 2026-03-05Clinical Trial Update: A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating CLBR001 and SWI019 in autoimmune diseases has been withdrawn from further development.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis [NA]
A clinical trial update shows ongoing research on fecal microbiota transplantation for chronic diarrhea in patients with systemic sclerosis.…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CD19-BCMA CAR T cell therapy for refractory lupus nephritis, systemic sclerosis, and primary Sjögren's…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH. [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Umbilical Cord Blood CD19-BCMA CART Cell Therapy for refractory lupus nephritis, systemic sclerosis, and primar…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases [Phase 1]
A Phase 1 exploratory study evaluating the safety and feasibility of YTS109 cell therapy for multiple autoimmune diseases, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases [Phase 1]
Phase 1 clinical study of YTS109 cell therapy for refractory autoimmune diseases is currently recruiting. The trial will evaluate safety and…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
An early-phase exploratory clinical study evaluating the safety and potential efficacy of an anti-CD19/BCMA U CAR-T cell therapy for relapse…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
A Yale University-led clinical trial is recruiting to quantify calcinosis cutis disease burden in patients with systemic sclerosis using com…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial of TI-0032-III Injection for relapsed and refractory autoimmune diseases is currently recruiting, encompassing seve…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis [Phase 2]
An open-label Phase 2 study evaluating the efficacy and safety of nemolizumab in systemic sclerosis has completed. Results have been posted.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) [Phase 2]
This document announces a Phase 2 clinical trial evaluating Tibulizumab for systemic sclerosis (scleroderma), which is currently recruiting …
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
A long-term follow-up study for participants previously treated with KYV-101; recruitment is ongoing across multiple autoimmune diseases.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of AZD0120 in Autoimmune Diseases [Phase 1]
AZD0120 from AstraZeneca is in Phase 1 testing for autoimmune diseases, including systemic sclerosis, idiopathic inflammatory myopathies, an…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Self-Guided Resilience-Building Energy Management to Enhance Well-being (RENEW) Intervention for People With Systemic Sclerosis (SSc) [NA]
ClinicalTrials.gov indicates the RENEW trial, evaluating a self-guided resilience-building energy management intervention for people with sy…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)
A Sohag University-led clinical trial investigates whether circulating fibroblast activation protein (FAP) levels correlate with fibrosis in…